European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management
Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
BioPredictive · FibroTest-ActiTest
BioPredictive · FibroMax
Fibromax
PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The “VARES” Italian multicenter study | Annals of Hepatology
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise | Nature Reviews Gastroenterology & Hepatology
Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The “VARES” Italian multicenter study | Annals of Hepatology
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus | Journal of Investigative Medicine
Non-invasive tests of non-alcoholic fatty liver disease | Chinese Medical Journal
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference | Request PDF
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
PDF) How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index)?
Clinical case: NAFLD
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data | PLOS ONE
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes - ScienceDirect
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers - ScienceDirect
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
